ABO Wind AG (AB9)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 3.595 |
|---|---|
| 52-week range | 1.504 – 35.700 |
| Return, 1 month / 3 months | +12.3% / +4.1% |
| Return, 1 year / 3 years | −89.7% / −91.8% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 150.9% |
| Worst drawdown (1 year) | -95.7% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ABO Wind AG is a German renewable energy company based in Wiesbaden. It develops, plans, finances and builds wind farms and solar parks, and it also provides operational management for plants once they are running. Its customers include landowners, investors and utilities that own or invest in renewable energy projects, and the company works on projects in Germany and other countries. Alongside wind and solar, it is involved in hybrid energy systems and related project services.
On this site ABO Wind AG appears as a stock on the XETRA Stock Exchange (Germany), code AB9, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ABO Wind AG (AB9) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 3.595 on 23 October 2026.
Its price-based Market X-Ray is 14 out of 100 (a weak price profile), ranking 664 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 89.7% and over the last three months it rose 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 6 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.2% | ||
| From 52-week high | -89.8% | ||
| Momentum | 26 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.1% | ||
| 6-month return | -37.8% | ||
| 12-month return, skipping the last month | -90.8% | ||
| Stability (higher is calmer) | 1 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 150.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -95.7% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −20.4% |
|---|---|
| 1 month | +12.3% |
| 3 months | +4.1% |
| 6 months | −37.8% |
| 1 year | −89.7% |
| 3 years | −91.8% |
| 5 years | −94.0% |
Signals
| 50-day / 200-day average | 3.296 / 4.744 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.804 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2025 | EUR 0.6500 |
| 2 May 2024 | EUR 0.6000 |
| 28 Apr 2023 | EUR 0.5400 |
| 29 Apr 2022 | EUR 0.4900 |
| 26 Apr 2021 | EUR 0.4500 |
| 21 Aug 2020 | EUR 0.4200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.